nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRFAM7A—corpus luteum—testicular cancer	0.142	0.434	CbGeAlD
Varenicline—CHRNA7—corpus luteum—testicular cancer	0.115	0.35	CbGeAlD
Varenicline—CHRNB2—female gonad—testicular cancer	0.0106	0.0323	CbGeAlD
Varenicline—CHRNB2—testis—testicular cancer	0.00937	0.0286	CbGeAlD
Varenicline—CHRNA3—testis—testicular cancer	0.00909	0.0278	CbGeAlD
Varenicline—CHRFAM7A—female gonad—testicular cancer	0.00829	0.0253	CbGeAlD
Varenicline—CHRFAM7A—testis—testicular cancer	0.00735	0.0224	CbGeAlD
Varenicline—CHRNB2—lymph node—testicular cancer	0.00679	0.0207	CbGeAlD
Varenicline—CHRNA7—female gonad—testicular cancer	0.00669	0.0204	CbGeAlD
Varenicline—CHRNA3—lymph node—testicular cancer	0.00659	0.0201	CbGeAlD
Varenicline—CHRNA7—testis—testicular cancer	0.00594	0.0181	CbGeAlD
Varenicline—Epistaxis—Epirubicin—testicular cancer	0.000484	0.00072	CcSEcCtD
Varenicline—Urethral disorder—Methotrexate—testicular cancer	0.000483	0.000718	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—testicular cancer	0.000482	0.000716	CcSEcCtD
Varenicline—Feeling abnormal—Etoposide—testicular cancer	0.000482	0.000716	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—testicular cancer	0.000481	0.000715	CcSEcCtD
Varenicline—Nausea—Dactinomycin—testicular cancer	0.00048	0.000713	CcSEcCtD
Varenicline—Gastrointestinal pain—Etoposide—testicular cancer	0.000478	0.000711	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—testicular cancer	0.000475	0.000707	CcSEcCtD
Varenicline—Infestation—Doxorubicin—testicular cancer	0.000475	0.000707	CcSEcCtD
Varenicline—Visual impairment—Methotrexate—testicular cancer	0.000475	0.000706	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000471	0.000701	CcSEcCtD
Varenicline—Vomiting—Ifosfamide—testicular cancer	0.00047	0.000699	CcSEcCtD
Varenicline—Hypersensitivity—Cisplatin—testicular cancer	0.00047	0.000699	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—testicular cancer	0.000469	0.000698	CcSEcCtD
Varenicline—Rash—Ifosfamide—testicular cancer	0.000466	0.000694	CcSEcCtD
Varenicline—Dermatitis—Ifosfamide—testicular cancer	0.000466	0.000693	CcSEcCtD
Varenicline—Erythema multiforme—Methotrexate—testicular cancer	0.000466	0.000693	CcSEcCtD
Varenicline—Urticaria—Etoposide—testicular cancer	0.000464	0.00069	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—testicular cancer	0.000463	0.000689	CcSEcCtD
Varenicline—Abdominal pain—Etoposide—testicular cancer	0.000462	0.000687	CcSEcCtD
Varenicline—Body temperature increased—Etoposide—testicular cancer	0.000462	0.000687	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—testicular cancer	0.000462	0.000687	CcSEcCtD
Varenicline—Eye disorder—Methotrexate—testicular cancer	0.00046	0.000685	CcSEcCtD
Varenicline—Tinnitus—Methotrexate—testicular cancer	0.000459	0.000683	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—testicular cancer	0.000459	0.000682	CcSEcCtD
Varenicline—Asthenia—Cisplatin—testicular cancer	0.000458	0.00068	CcSEcCtD
Varenicline—Cardiac disorder—Methotrexate—testicular cancer	0.000457	0.00068	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—testicular cancer	0.000455	0.000677	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—testicular cancer	0.000454	0.000675	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—testicular cancer	0.000453	0.000674	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—testicular cancer	0.000452	0.000672	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000449	0.000668	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—testicular cancer	0.000448	0.000666	CcSEcCtD
Varenicline—Angiopathy—Methotrexate—testicular cancer	0.000447	0.000665	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—testicular cancer	0.000446	0.000663	CcSEcCtD
Varenicline—Immune system disorder—Methotrexate—testicular cancer	0.000445	0.000662	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—testicular cancer	0.000444	0.000661	CcSEcCtD
Varenicline—Mediastinal disorder—Methotrexate—testicular cancer	0.000444	0.00066	CcSEcCtD
Varenicline—Chills—Methotrexate—testicular cancer	0.000442	0.000657	CcSEcCtD
Varenicline—Nausea—Ifosfamide—testicular cancer	0.000439	0.000653	CcSEcCtD
Varenicline—Diarrhoea—Cisplatin—testicular cancer	0.000436	0.000649	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—testicular cancer	0.000436	0.000648	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—testicular cancer	0.000434	0.000646	CcSEcCtD
Varenicline—Mental disorder—Methotrexate—testicular cancer	0.000432	0.000642	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—testicular cancer	0.000431	0.000641	CcSEcCtD
Varenicline—Hypersensitivity—Etoposide—testicular cancer	0.000431	0.00064	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—testicular cancer	0.00043	0.000639	CcSEcCtD
Varenicline—Erythema—Methotrexate—testicular cancer	0.000429	0.000638	CcSEcCtD
Varenicline—Malnutrition—Methotrexate—testicular cancer	0.000429	0.000638	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—testicular cancer	0.000428	0.000636	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—testicular cancer	0.000424	0.000631	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—testicular cancer	0.000421	0.000626	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—testicular cancer	0.00042	0.000625	CcSEcCtD
Varenicline—Dysgeusia—Methotrexate—testicular cancer	0.00042	0.000624	CcSEcCtD
Varenicline—Asthenia—Etoposide—testicular cancer	0.000419	0.000623	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—testicular cancer	0.000419	0.000623	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—testicular cancer	0.000418	0.000622	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—testicular cancer	0.000418	0.000622	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—testicular cancer	0.000416	0.000619	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—testicular cancer	0.000416	0.000618	CcSEcCtD
Varenicline—Back pain—Methotrexate—testicular cancer	0.000415	0.000617	CcSEcCtD
Varenicline—Chills—Epirubicin—testicular cancer	0.000414	0.000615	CcSEcCtD
Varenicline—Pruritus—Etoposide—testicular cancer	0.000413	0.000615	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—testicular cancer	0.000412	0.000612	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—testicular cancer	0.000411	0.000611	CcSEcCtD
Varenicline—Vomiting—Cisplatin—testicular cancer	0.000406	0.000603	CcSEcCtD
Varenicline—Vision blurred—Methotrexate—testicular cancer	0.000404	0.000601	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—testicular cancer	0.000404	0.000601	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—testicular cancer	0.000403	0.0006	CcSEcCtD
Varenicline—Rash—Cisplatin—testicular cancer	0.000402	0.000598	CcSEcCtD
Varenicline—Dermatitis—Cisplatin—testicular cancer	0.000402	0.000597	CcSEcCtD
Varenicline—Erythema—Epirubicin—testicular cancer	0.000401	0.000597	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—testicular cancer	0.000401	0.000597	CcSEcCtD
Varenicline—Diarrhoea—Etoposide—testicular cancer	0.0004	0.000594	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—testicular cancer	0.000399	0.000593	CcSEcCtD
Varenicline—Ill-defined disorder—Methotrexate—testicular cancer	0.000398	0.000592	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—testicular cancer	0.000398	0.000591	CcSEcCtD
Varenicline—Anaemia—Methotrexate—testicular cancer	0.000396	0.000589	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—testicular cancer	0.000396	0.000589	CcSEcCtD
Varenicline—Flatulence—Epirubicin—testicular cancer	0.000395	0.000588	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—testicular cancer	0.000393	0.000584	CcSEcCtD
Varenicline—Back pain—Epirubicin—testicular cancer	0.000388	0.000577	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—testicular cancer	0.000387	0.000576	CcSEcCtD
Varenicline—Malaise—Methotrexate—testicular cancer	0.000387	0.000575	CcSEcCtD
Varenicline—Dizziness—Etoposide—testicular cancer	0.000386	0.000575	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—testicular cancer	0.000386	0.000574	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—testicular cancer	0.000385	0.000573	CcSEcCtD
Varenicline—Vertigo—Methotrexate—testicular cancer	0.000385	0.000573	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—testicular cancer	0.000384	0.000572	CcSEcCtD
Varenicline—Chills—Doxorubicin—testicular cancer	0.000383	0.000569	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—testicular cancer	0.000381	0.000567	CcSEcCtD
Varenicline—Nausea—Cisplatin—testicular cancer	0.000379	0.000563	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—testicular cancer	0.000378	0.000562	CcSEcCtD
Varenicline—Cough—Methotrexate—testicular cancer	0.000374	0.000556	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—testicular cancer	0.000374	0.000556	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—testicular cancer	0.000372	0.000554	CcSEcCtD
Varenicline—Convulsion—Methotrexate—testicular cancer	0.000372	0.000553	CcSEcCtD
Varenicline—Vomiting—Etoposide—testicular cancer	0.000372	0.000552	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—testicular cancer	0.000371	0.000552	CcSEcCtD
Varenicline—Erythema—Doxorubicin—testicular cancer	0.000371	0.000552	CcSEcCtD
Varenicline—Anaemia—Epirubicin—testicular cancer	0.000371	0.000552	CcSEcCtD
Varenicline—Agitation—Epirubicin—testicular cancer	0.000369	0.000548	CcSEcCtD
Varenicline—Rash—Etoposide—testicular cancer	0.000368	0.000548	CcSEcCtD
Varenicline—Dermatitis—Etoposide—testicular cancer	0.000368	0.000547	CcSEcCtD
Varenicline—Headache—Etoposide—testicular cancer	0.000366	0.000544	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—testicular cancer	0.000366	0.000544	CcSEcCtD
Varenicline—Chest pain—Methotrexate—testicular cancer	0.000365	0.000543	CcSEcCtD
Varenicline—Myalgia—Methotrexate—testicular cancer	0.000365	0.000543	CcSEcCtD
Varenicline—Arthralgia—Methotrexate—testicular cancer	0.000365	0.000543	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—testicular cancer	0.000364	0.000541	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000363	0.000539	CcSEcCtD
Varenicline—Malaise—Epirubicin—testicular cancer	0.000362	0.000538	CcSEcCtD
Varenicline—Discomfort—Methotrexate—testicular cancer	0.000361	0.000536	CcSEcCtD
Varenicline—Vertigo—Epirubicin—testicular cancer	0.000361	0.000536	CcSEcCtD
Varenicline—Syncope—Epirubicin—testicular cancer	0.00036	0.000535	CcSEcCtD
Varenicline—Back pain—Doxorubicin—testicular cancer	0.000359	0.000534	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—testicular cancer	0.000357	0.000531	CcSEcCtD
Varenicline—Palpitations—Epirubicin—testicular cancer	0.000355	0.000527	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—testicular cancer	0.000353	0.000525	CcSEcCtD
Varenicline—Cough—Epirubicin—testicular cancer	0.00035	0.000521	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—testicular cancer	0.00035	0.00052	CcSEcCtD
Varenicline—Convulsion—Epirubicin—testicular cancer	0.000348	0.000517	CcSEcCtD
Varenicline—Infection—Methotrexate—testicular cancer	0.000348	0.000517	CcSEcCtD
Varenicline—Nausea—Etoposide—testicular cancer	0.000347	0.000516	CcSEcCtD
Varenicline—Hypertension—Epirubicin—testicular cancer	0.000347	0.000515	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—testicular cancer	0.000345	0.000512	CcSEcCtD
Varenicline—Nervous system disorder—Methotrexate—testicular cancer	0.000343	0.00051	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—testicular cancer	0.000343	0.00051	CcSEcCtD
Varenicline—Thrombocytopenia—Methotrexate—testicular cancer	0.000343	0.00051	CcSEcCtD
Varenicline—Myalgia—Epirubicin—testicular cancer	0.000342	0.000508	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—testicular cancer	0.000342	0.000508	CcSEcCtD
Varenicline—Chest pain—Epirubicin—testicular cancer	0.000342	0.000508	CcSEcCtD
Varenicline—Agitation—Doxorubicin—testicular cancer	0.000341	0.000507	CcSEcCtD
Varenicline—Anxiety—Epirubicin—testicular cancer	0.000341	0.000506	CcSEcCtD
Varenicline—Skin disorder—Methotrexate—testicular cancer	0.00034	0.000506	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000339	0.000505	CcSEcCtD
Varenicline—Hyperhidrosis—Methotrexate—testicular cancer	0.000338	0.000503	CcSEcCtD
Varenicline—Discomfort—Epirubicin—testicular cancer	0.000338	0.000502	CcSEcCtD
Varenicline—Malaise—Doxorubicin—testicular cancer	0.000335	0.000498	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—testicular cancer	0.000334	0.000497	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—testicular cancer	0.000334	0.000496	CcSEcCtD
Varenicline—Anorexia—Methotrexate—testicular cancer	0.000334	0.000496	CcSEcCtD
Varenicline—Syncope—Doxorubicin—testicular cancer	0.000333	0.000495	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—testicular cancer	0.000328	0.000488	CcSEcCtD
Varenicline—Oedema—Epirubicin—testicular cancer	0.000328	0.000487	CcSEcCtD
Varenicline—Hypotension—Methotrexate—testicular cancer	0.000327	0.000486	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—testicular cancer	0.000326	0.000485	CcSEcCtD
Varenicline—Infection—Epirubicin—testicular cancer	0.000325	0.000484	CcSEcCtD
Varenicline—Cough—Doxorubicin—testicular cancer	0.000324	0.000482	CcSEcCtD
Varenicline—Shock—Epirubicin—testicular cancer	0.000322	0.000479	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—testicular cancer	0.000322	0.000478	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—testicular cancer	0.000321	0.000478	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—testicular cancer	0.000321	0.000477	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—testicular cancer	0.000321	0.000477	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—testicular cancer	0.00032	0.000475	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000319	0.000474	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—testicular cancer	0.000318	0.000473	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—testicular cancer	0.000317	0.000471	CcSEcCtD
Varenicline—Insomnia—Methotrexate—testicular cancer	0.000317	0.000471	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—testicular cancer	0.000316	0.00047	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—testicular cancer	0.000316	0.00047	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—testicular cancer	0.000316	0.00047	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—testicular cancer	0.000315	0.000468	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000314	0.000467	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—testicular cancer	0.000312	0.000464	CcSEcCtD
Varenicline—Anorexia—Epirubicin—testicular cancer	0.000312	0.000464	CcSEcCtD
Varenicline—Dyspnoea—Methotrexate—testicular cancer	0.000312	0.000464	CcSEcCtD
Varenicline—Somnolence—Methotrexate—testicular cancer	0.000311	0.000463	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—testicular cancer	0.000309	0.00046	CcSEcCtD
Varenicline—Dyspepsia—Methotrexate—testicular cancer	0.000308	0.000458	CcSEcCtD
Varenicline—Hypotension—Epirubicin—testicular cancer	0.000306	0.000455	CcSEcCtD
Varenicline—Decreased appetite—Methotrexate—testicular cancer	0.000304	0.000452	CcSEcCtD
Varenicline—Oedema—Doxorubicin—testicular cancer	0.000303	0.000451	CcSEcCtD
Varenicline—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000302	0.000449	CcSEcCtD
Varenicline—Fatigue—Methotrexate—testicular cancer	0.000302	0.000449	CcSEcCtD
Varenicline—Infection—Doxorubicin—testicular cancer	0.000301	0.000448	CcSEcCtD
Varenicline—Pain—Methotrexate—testicular cancer	0.000299	0.000445	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000298	0.000444	CcSEcCtD
Varenicline—Shock—Doxorubicin—testicular cancer	0.000298	0.000443	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—testicular cancer	0.000297	0.000442	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—testicular cancer	0.000297	0.000441	CcSEcCtD
Varenicline—Insomnia—Epirubicin—testicular cancer	0.000296	0.000441	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—testicular cancer	0.000296	0.00044	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—testicular cancer	0.000294	0.000438	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—testicular cancer	0.000293	0.000436	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—testicular cancer	0.000292	0.000434	CcSEcCtD
Varenicline—Somnolence—Epirubicin—testicular cancer	0.000291	0.000433	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—testicular cancer	0.000289	0.00043	CcSEcCtD
Varenicline—Feeling abnormal—Methotrexate—testicular cancer	0.000288	0.000429	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—testicular cancer	0.000288	0.000429	CcSEcCtD
Varenicline—Gastrointestinal pain—Methotrexate—testicular cancer	0.000286	0.000426	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—testicular cancer	0.000285	0.000423	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—testicular cancer	0.000283	0.000421	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000283	0.00042	CcSEcCtD
Varenicline—Fatigue—Epirubicin—testicular cancer	0.000282	0.00042	CcSEcCtD
Varenicline—Constipation—Epirubicin—testicular cancer	0.00028	0.000416	CcSEcCtD
Varenicline—Pain—Epirubicin—testicular cancer	0.00028	0.000416	CcSEcCtD
Varenicline—Urticaria—Methotrexate—testicular cancer	0.000278	0.000413	CcSEcCtD
Varenicline—Body temperature increased—Methotrexate—testicular cancer	0.000277	0.000411	CcSEcCtD
Varenicline—Abdominal pain—Methotrexate—testicular cancer	0.000277	0.000411	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000276	0.000411	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—testicular cancer	0.000274	0.000408	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—testicular cancer	0.00027	0.000402	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—testicular cancer	0.00027	0.000401	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—testicular cancer	0.000269	0.000401	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—testicular cancer	0.000268	0.000398	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—testicular cancer	0.000267	0.000397	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—testicular cancer	0.000263	0.000392	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000262	0.000389	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—testicular cancer	0.000261	0.000389	CcSEcCtD
Varenicline—Urticaria—Epirubicin—testicular cancer	0.00026	0.000387	CcSEcCtD
Varenicline—Constipation—Doxorubicin—testicular cancer	0.000259	0.000385	CcSEcCtD
Varenicline—Pain—Doxorubicin—testicular cancer	0.000259	0.000385	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—testicular cancer	0.000259	0.000385	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—testicular cancer	0.000259	0.000385	CcSEcCtD
Varenicline—Hypersensitivity—Methotrexate—testicular cancer	0.000258	0.000383	CcSEcCtD
Varenicline—Asthenia—Methotrexate—testicular cancer	0.000251	0.000373	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—testicular cancer	0.00025	0.000371	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000248	0.000369	CcSEcCtD
Varenicline—Pruritus—Methotrexate—testicular cancer	0.000248	0.000368	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—testicular cancer	0.000241	0.000359	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—testicular cancer	0.000241	0.000358	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—testicular cancer	0.00024	0.000356	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—testicular cancer	0.00024	0.000356	CcSEcCtD
Varenicline—Diarrhoea—Methotrexate—testicular cancer	0.000239	0.000356	CcSEcCtD
Varenicline—Asthenia—Epirubicin—testicular cancer	0.000235	0.000349	CcSEcCtD
Varenicline—Pruritus—Epirubicin—testicular cancer	0.000232	0.000345	CcSEcCtD
Varenicline—Dizziness—Methotrexate—testicular cancer	0.000231	0.000344	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—testicular cancer	0.000224	0.000333	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—testicular cancer	0.000223	0.000332	CcSEcCtD
Varenicline—Vomiting—Methotrexate—testicular cancer	0.000223	0.000331	CcSEcCtD
Varenicline—Rash—Methotrexate—testicular cancer	0.000221	0.000328	CcSEcCtD
Varenicline—Dermatitis—Methotrexate—testicular cancer	0.00022	0.000328	CcSEcCtD
Varenicline—Headache—Methotrexate—testicular cancer	0.000219	0.000326	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—testicular cancer	0.000217	0.000323	CcSEcCtD
Varenicline—Dizziness—Epirubicin—testicular cancer	0.000217	0.000322	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—testicular cancer	0.000214	0.000319	CcSEcCtD
Varenicline—Vomiting—Epirubicin—testicular cancer	0.000208	0.00031	CcSEcCtD
Varenicline—Nausea—Methotrexate—testicular cancer	0.000208	0.000309	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—testicular cancer	0.000207	0.000308	CcSEcCtD
Varenicline—Rash—Epirubicin—testicular cancer	0.000207	0.000307	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—testicular cancer	0.000206	0.000307	CcSEcCtD
Varenicline—Headache—Epirubicin—testicular cancer	0.000205	0.000305	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—testicular cancer	0.0002	0.000298	CcSEcCtD
Varenicline—Nausea—Epirubicin—testicular cancer	0.000195	0.000289	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—testicular cancer	0.000193	0.000287	CcSEcCtD
Varenicline—Rash—Doxorubicin—testicular cancer	0.000191	0.000284	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—testicular cancer	0.000191	0.000284	CcSEcCtD
Varenicline—Headache—Doxorubicin—testicular cancer	0.00019	0.000282	CcSEcCtD
Varenicline—Nausea—Doxorubicin—testicular cancer	0.00018	0.000268	CcSEcCtD
